Revelar Biotherapeutics
Bethesda, US · Founded 2021 · Delaware corporation
Founders & leadership
LS
Laurence SmithNamed on SEC filing
DS
David ScheerNamed on SEC filing
GM
Glenn MarinaNamed on SEC filing
BG
Brett GiroirNamed on SEC filing
PF
Paul FonteyneNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$18.5M disclosed across 2 rounds · 2021–2022
▶$1MraisedFeb 2022 · 1 investors · BiotechnologyRule 506(b)
▶$1MraisedFeb 2022 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul FonteyneDirector
- Glenn MarinaExecutive Officer, Director
- Laurence SmithExecutive Officer
- David ScheerDirector
- Brett GiroirDirector
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- Feb 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$17.5MraisedNov 2021 · 1 investors · BiotechnologyRule 506(b)
▶$17.5MraisedNov 2021 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Laurence SmithExecutive Officer
- David ScheerDirector
- Glenn MarinaExecutive Officer, Director
- Brett GiroirDirector
- Paul FonteyneDirector
- Offering amount
- $22.5M
- Amount sold
- $17.5M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Revelar Biotherapeutics raised?
- Revelar Biotherapeutics has disclosed $18.5M raised across 2 rounds.
- Where is Revelar Biotherapeutics headquartered?
- Revelar Biotherapeutics is headquartered in Bethesda, US.